Benjamin Blasco joined GARDP in November 2018 as a Discovery Senior Project Manager to provide scientific support and leadership to a number of drug discovery project teams working on novel approaches to treat drug-resistant bacterial infections.
Benjamin has over 10 years’ experience working on two of the “big three” infectious diseases (tuberculosis and malaria), with a broad expertise in microbiology, molecular pharmacology and drug discovery. Prior to joining GARDP, Benjamin worked as a Research Scientist at Medicines for Malaria Venture, managing several projects spanning from biology test platforms to drug discovery programmes. In particular, he delivered antimalarial drug resistance data and strategy through projects in collaboration with academic leaders in this field and expert investigators working closely with clinical sites in Africa.
Before that, he studied virulence regulators of Mycobacterium tuberculosis at the chair of Microbial Pathogenesis of Prof. Stewart Cole (Global Health Institute, EPFL) and developed a mycobacterial assay to screen for anti-virulence compounds.
Benjamin holds a Master degree in Molecular and Biological Chemistry and a PhD in Molecular Life Sciences from the Swiss Federal Institute of Technology in Lausanne (EPFL). He also obtained his Project Management Professional (PMP) certification in 2017.